The Manila Times

Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal O…

Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire ...
Medscape

GLP-1s Linked to Better Seizure Control in Epilepsy

GLP-1s are linked to lower seizure recurrence, hospitalization, and mortality risk than other glucose-lowering drugs in ...
Fierce Biotech

Praxis claims efficacy success in phase 2 seizure trial, setting up approval talks with FDA

“SCN2A and SCN8A DEEs are devastating conditions with extremely high mortality due to the debilitating seizure burden they ...

First seizure clinic speeds time to diagnosis with pediatric epilepsy

Children referred to a first seizure clinic (FSC) see a neurologist epilepsy specialist within one week, according to a study ...
The American Journal of Managed Care

Lumateperone Improves Depression in Patients With Inadequate Antidepressant Response

Adding lumateperone (Caplyta; Johnson & Johnson) to ongoing antidepressant therapy (ADT) significantly improved depression severity in adults with major depressive disorder (MDD) who had not responded ...